{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:40:41Z","timestamp":1790336441912,"version":"4.1.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4,1]]},"DOI":"10.1093\/aje\/kwr362","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T16:30:36Z","timestamp":1330965036000},"page":"627-635","source":"Crossref","is-referenced-by-count":140,"title":["Use of Calcium Channel Blockers and Parkinson\u2019s Disease"],"prefix":"10.1093","volume":"175","author":[{"given":"Bj\u00f6rn","family":"Pasternak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Svanstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nete M.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Fugger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Melbye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Hviid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,3,1]]},"reference":[{"issue":"6","key":"key\n\t\t\t\t20170522112453_bib1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol"},{"issue":"9423","key":"key\n\t\t\t\t20170522112453_bib2","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson\u2019s disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"key\n\t\t\t\t20170522112453_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1474-4422(03)00351-X","article-title":"Dementia associated with Parkinson\u2019s disease","volume":"2","author":"Emre","year":"2003","journal-title":"Lancet Neurol"},{"issue":"13","key":"key\n\t\t\t\t20170522112453_bib4","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","article-title":"A double-blind, delayed-start trial of rasagiline in Parkinson\u2019s disease","volume":"361","author":"Olanow","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"key\n\t\t\t\t20170522112453_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1474-9726.2007.00275.x","article-title":"Calcium and neurodegeneration","volume":"6","author":"Mattson","year":"2007","journal-title":"Aging Cell"},{"issue":"10","key":"key\n\t\t\t\t20170522112453_bib6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1474-4422(07)70246-6","article-title":"Calcium, ageing, and neuronal vulnerability in Parkinson\u2019s disease","volume":"6","author":"Surmeier","year":"2007","journal-title":"Lancet Neurol"},{"issue":"4","key":"key\n\t\t\t\t20170522112453_bib7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00001756-199503000-00009","article-title":"Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice","volume":"6","author":"Kupsch","year":"1995","journal-title":"Neuroreport"},{"issue":"1-2","key":"key\n\t\t\t\t20170522112453_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0006-8993(96)00917-1","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level","volume":"741","author":"Kupsch","year":"1996","journal-title":"Brain Res"},{"issue":"7148","key":"key\n\t\t\t\t20170522112453_bib9","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nature05865","article-title":"\u2018Rejuvenation\u2019 protects neurons in mouse models of Parkinson\u2019s disease","volume":"447","author":"Chan","year":"2007","journal-title":"Nature"},{"issue":"16","key":"key\n\t\t\t\t20170522112453_bib10","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1212\/01.wnl.0000303818.38960.44","article-title":"Use of antihypertensives and the risk of Parkinson disease","volume":"70","author":"Becker","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"key\n\t\t\t\t20170522112453_bib11","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ana.21937","article-title":"L-type calcium channel blockers and Parkinson disease in Denmark","volume":"67","author":"Ritz","year":"2010","journal-title":"Ann Neurol"},{"issue":"3","key":"key\n\t\t\t\t20170522112453_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.parkreldis.2006.08.011","article-title":"Calcium channel blockers and beta blockers in relation to Parkinson\u2019s disease","volume":"13","author":"Ton","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"key\n\t\t\t\t20170522112453_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000235641","article-title":"Antihypertensive agents and risk of Parkinson\u2019s disease, essential tremor and dementia: a population-based prospective study (NEDICES)","volume":"33","author":"Louis","year":"2009","journal-title":"Neuroepidemiology"},{"issue":"12","key":"key\n\t\t\t\t20170522112453_bib14","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/mds.23191","article-title":"Calcium channel blocker use and risk of Parkinson\u2019s disease","volume":"25","author":"Simon","year":"2010","journal-title":"Mov Disord"},{"issue":"4","key":"key\n\t\t\t\t20170522112453_bib15","first-page":"441","article-title":"The Danish Civil Registration System. A cohort of eight million persons","volume":"53","author":"Pedersen","year":"2006","journal-title":"Dan Med Bull"},{"key":"key\n\t\t\t\t20170522112453_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"issue":"9","key":"key\n\t\t\t\t20170522112453_bib17","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"3","key":"key\n\t\t\t\t20170522112453_bib18","first-page":"263","article-title":"The Danish National Hospital Register. A valuable source of data for modern health sciences","volume":"46","author":"Andersen","year":"1999","journal-title":"Dan Med Bull"},{"issue":"4","key":"key\n\t\t\t\t20170522112453_bib19","first-page":"354","article-title":"The Danish registers of causes of death","volume":"46","author":"Juel","year":"1999","journal-title":"Dan Med Bull"},{"issue":"5","key":"key\n\t\t\t\t20170522112453_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"11","key":"key\n\t\t\t\t20170522112453_bib21","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"key\n\t\t\t\t20170522112453_bib22","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1212\/WNL.66.10_suppl_4.S24","article-title":"The pathogenesis of cell death in Parkinson\u2019s disease","volume":"66","author":"Jenner","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"key\n\t\t\t\t20170522112453_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molmed.2009.01.001","article-title":"Calcium signaling and neurodegenerative diseases","volume":"15","author":"Bezprozvanny","year":"2009","journal-title":"Trends Mol Med"},{"issue":"12","key":"key\n\t\t\t\t20170522112453_bib24","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ng.485","article-title":"Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\u2019s disease","volume":"41","author":"Satake","year":"2009","journal-title":"Nat Genet"},{"issue":"4","key":"key\n\t\t\t\t20170522112453_bib25","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/373937","article-title":"Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease","volume":"72","author":"van der Walt","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"8","key":"key\n\t\t\t\t20170522112453_bib26","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1371\/journal.pgen.0020128","article-title":"Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics","volume":"2","author":"Kazuno","year":"2006","journal-title":"PLoS Genet"},{"issue":"5674","key":"key\n\t\t\t\t20170522112453_bib27","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"issue":"5","key":"key\n\t\t\t\t20170522112453_bib28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.molcel.2009.02.013","article-title":"PINK1-associated Parkinson\u2019s disease is caused by neuronal vulnerability to calcium-induced cell death","volume":"33","author":"Gandhi","year":"2009","journal-title":"Mol Cell"},{"issue":"4","key":"key\n\t\t\t\t20170522112453_bib29","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1046\/j.1471-4159.1999.721448.x","article-title":"Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells","volume":"72","author":"Mason","year":"1999","journal-title":"J Neurochem"},{"issue":"17","key":"key\n\t\t\t\t20170522112453_bib30","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/01.wnl.0000271883.45010.8a","article-title":"Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease","volume":"69","author":"Simon","year":"2007","journal-title":"Neurology"},{"issue":"21","key":"key\n\t\t\t\t20170522112453_bib31","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0024-3205(97)00881-3","article-title":"Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists","volume":"61","author":"Uchida","year":"1997","journal-title":"Life Sci"},{"issue":"1","key":"key\n\t\t\t\t20170522112453_bib32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10286-006-0317-8","article-title":"Orthostatic hypotension as an early finding in Parkinson\u2019s disease","volume":"16","author":"Goldstein","year":"2006","journal-title":"Clin Auton Res"},{"issue":"3","key":"key\n\t\t\t\t20170522112453_bib33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/archneur.63.3.noc50312","article-title":"Subjective complaints precede Parkinson disease: the Rotterdam Study","volume":"63","author":"de Lau","year":"2006","journal-title":"Arch Neurol"},{"issue":"3","key":"key\n\t\t\t\t20170522112453_bib34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.10277","article-title":"A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson\u2019s disease","volume":"52","author":"Hern\u00e1n","year":"2002","journal-title":"Ann Neurol"},{"issue":"5","key":"key\n\t\t\t\t20170522112453_bib35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/175\/7\/627\/17339605\/kwr362.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T00:27:47Z","timestamp":1713659267000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article-lookup\/doi\/10.1093\/aje\/kwr362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,1]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,3,1]]},"published-print":{"date-parts":[[2012,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwr362","relation":{},"ISSN":["1476-6256","0002-9262"],"issn-type":[{"value":"1476-6256","type":"electronic"},{"value":"0002-9262","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3,1]]}}}